Loading clinical trials...

Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGPHASE4

Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia

The Effect of Probiotic Administration on the Incidence of Antibiotic-associated Diarrhea in Patients With Community-acquired Pneumonia

NCT06990568•National Health Insurance Service Ilsan Hospital

View on ClinicalTrials.gov

Summary

The study goal is to determine whether oral administration of a probiotic mixture can reduce the incidence of antibiotic-associated diarrhea in patients with community-acquired pneumonia.

Eligibility

Age

19 - 79 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Adult patients aged 19 years or older admitted with a diagnosis of community-acquired pneumonia
•Patients eligible for oral medication administration (able to take oral or enteral feeding)

Exclusion Criteria

•Sepsis patients
•Patients admitted to the intensive care unit (ICU) following endotracheal intubation
•Elderly patients aged 80 years or older
•Pregnant women
•Patients who have diarrhea at the time of admission
•Patients with a history of using probiotics within 3 months prior to admission
•Patients with a history of using laxatives within 1 week prior to admission
•Patients suspected of being in shock (mean arterial pressure \< 65 mmHg) at the time of admission

Key Dates

Start Date

June 1, 2025

Primary Completion Date

May 31, 2026

Completion Date

December 31, 2026

Last Updated

May 25, 2025

Enrollment

100

ESTIMATED participants

Conditions

PneumoniaProbioticsDiarrhea

Interventions

Lacidofil

DRUG

Placebo

DRUG

Contacts

Eunki Chung, MD

CONTACT

+82-31-900-3235 ekchung@nhimc.or.kr

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

NCT06237452

Clostridium DifficileClostridium Difficile Infections+8 more

View study

RECRUITINGPHASE4

Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients

NCT07409727

Ventilation Acquired Pneumonia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 25, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia

Inclusion Criteria

Exclusion Criteria

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications

Health Systems and Policy Contexts of Medical Oxygen

Performance of New Diagnostic Methods in Older Adults With Pneumonia